The Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna, Novavax-Sanofi and Pfizer-BioNTech. All three vaccines are designed to prevent severe disease caused by the dominant strain, the JN.1 lineage XFG subvariant.
The FDA approved the vaccines for adults 65 and older, as well as younger people with one or more chronic conditions that put them at higher risk for severe disease, the companies announced yesterday.
Each vaccine approval is slightly different.
- Pfizer’s mRNA vaccine, Comirnity XFG, is approved for adults 65 years and older, and people ages 5 to 64 years old with an underlying condition. Pfizer said in a press release that it has already begun distributing vaccines, and that they should arrive in pharmacies soon.
- Moderna’s mRNA vaccine, Spikevax, is approved for people age 65 and older, and those 6 months to 64 years old with an underlying condition. Moderna’s new, lower-dose vaccine, mNEXSPIKE, is approved for people age 65 and older, as well as people 12 to 64 years old with an underlying condition.
- Sanofi also has received FDA approval for its COVID-19 vaccine, Nuvaxovid, originally licensed by Novavax, which does not use mRNA technology. Nuvaxovid is approved for adults ages 65 years and older, and people ages 12 years to 64 years who are at high risk for severe COVID-19.
Many conditions can increase the risk of developing a severe case of COVID-19, according to the Centers for Disease Control and Prevention (CDC). These include asthma, cancer, chronic lung or kidney disease, mental illness, obesity, pregnancy, and smoking.
According to the CDC, cases of COVID-19 are “growing or likely growing” in 48 states.
Most insurance plans will cover the updated shots
AHIP, an organization that includes most health insurers, has said that its members will cover the total cost of vaccines recommended by a CDC committee at least until the end of 2027.
CVS, one of the country's largest drugstore chains, is currently advertising “free COVID-19 vaccines with most insurance,” but notes that appointments may be unavailable in some states.